Founding Partner
Medical devices are intended to help diagnose, treat, or manage health conditions safely. When a defect is discovered, the consequences for patients can be catastrophic. That is the case with Olympus’s recall of certain ViziShot 2 FLEX (19G) Endoscopic Aspiration Needles, which the U.S. Food and Drug Administration (FDA) has classified as a Class I recall, the most serious category reserved for devices that may cause severe injury or death.
The recall was initiated after Olympus identified that some of these devices may have deformed a-traumatic tips, posing a risk of breakage, loose components entering the airway, bleeding, infection, and even fatal outcomes. To date, Olympus has acknowledged at least 14 reported injuries and one death linked to the defect. Patients and families affected by this recall may be eligible to pursue legal claims for compensation.
The ViziShot 2 FLEX (19G) is a tissue biopsy device used during endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) and fine needle biopsy (EUS-FNB). These procedures allow doctors to obtain tissue samples from abnormalities under the mucosal lining or from structures outside the tracheobronchial tree, such as suspected tumors or lymph nodes.
The device is made up of four parts:
Physicians insert the device through an ultrasound endoscope to reach deep into the airways and collect tissue samples for diagnosis. When functioning properly, the device is critical for detecting serious conditions, including lung cancer. However, the discovery of defects in certain batches raises serious safety concerns for patients who have undergone these procedures.
Olympus initiated the recall because some ViziShot 2 FLEX (19G) devices were manufactured with potentially deformed a-traumatic tips. This flaw increases the risk of:
The FDA warned that these risks can result in severe health outcomes, including the need for additional invasive procedures to remove foreign objects, permanent airway damage, and death.
As of August 2025, Olympus confirmed 14 serious injuries and one death linked to the defective devices. Reported complications include:
The single fatality underscores the life-threatening nature of the defect. Even when patients survive, the complications can lead to prolonged hospitalizations, long-term medical care, and permanent health consequences.
The FDA designated this as a Class I recall, the most severe level, reserved for situations where continued use of a device could cause serious injury or death.
On August 6, 2025, Olympus issued an Urgent Medical Device Removal letter to all affected customers. The letter instructed medical facilities to:
The company also reinforced existing warnings from its Instructions for Use (IFU), cautioning against forcing the device if resistance is encountered during procedures.
The defective ViziShot 2 FLEX (19G) needles pose multiple risks to patients:
Patients who underwent an endoscopic biopsy with a ViziShot 2 FLEX needle may not know whether their procedure involved a defective lot number. Medical providers are responsible for reviewing inventory and identifying affected patients. However, patients who experience unusual symptoms following an endoscopic biopsy—such as persistent coughing, chest pain, fever, shortness of breath, or unexplained bleeding—should seek medical evaluation immediately.
The recall covers devices distributed from August 4, 2022, to April 25, 2025, with expiration dates of March 25, 2028, or earlier.
Patients harmed by defective medical devices may be entitled to financial compensation. Potential claims may include:
Because the FDA has already classified this as a Class I recall with documented injuries and a fatality, patients and families may have strong grounds for legal action.
If you or a loved one suffered injuries after undergoing a biopsy procedure with an Olympus ViziShot 2 FLEX (19G) Endoscopic Aspiration Needle, you may be entitled to significant financial compensation. Parker Waichman LLP is a national personal injury law firm investigating claims connected to this Class I FDA recall.
Call 1-800-YOUR-LAWYER (1-800-968-7529) today for a free consultation. Our attorneys will review your case, explain your rights, and fight to secure the compensation you deserve. Regardless of your location or where your injury occurred, our nationwide defective medical device lawsuit lawyer are ready to assist you.
Parker Waichman LLP
Our law firm is ready to represent you in your injury case. We’ve helped many New York residents as well as those needing help nationwide. Contact our team for a free case consultation today.
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
Parker Waichman LLP
27299 Riverview Center Boulevard, Suite 108
Bonita Springs, FL 34134
We handle mass torts cases nationwide. Please contact our office to learn more.